AIG
DNTH icon

American International Group’s Dianthus Therapeutics DNTH Stock Holding History

American International Group’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-928
Closed -$43K – 3138
2022
Q1 		$43K Sell
928
-66
-7% -$3.61K ﹤0.01% 2894
2021
Q4 		$70K Sell
994
-29
-3% -$2.92K ﹤0.01% 2850
2021
Q3 		$119K Sell
1,023
-25
-2% -$2.91K ﹤0.01% 2722
2021
Q2 		$164K Buy
1,048
+294
+39% +$54K ﹤0.01% 2631
2021
Q1 		$143K Buy
754
+2
+0.3% +$337 ﹤0.01% 2538
2020
Q4 		$94K Sell
752
-22
-3% -$2.49K ﹤0.01% 2691
2020
Q3 		$84K Buy
774
+126
+19% +$14.9K ﹤0.01% 2616
2020
Q2 		$78K Sell
648
-63
-9% -$8.88K ﹤0.01% 2678
2020
Q1 		$71K Sell
711
-41
-5% -$7.6K ﹤0.01% 2507
2019
Q4 		$182K Sell
752
-6
-0.8% -$1.12K ﹤0.01% 2283
2019
Q3 		$124K Sell
758
-16
-2% -$3.04K ﹤0.01% 2473
2019
Q2 		$183K Buy
774
+200
+35% +$49.5K ﹤0.01% 2284
2019
Q1 		$151K Buy
574
+415
+261% +$71.6K ﹤0.01% 2366
2018
Q4 		$15K Sell
159
-8
-5% -$1.09K ﹤0.01% 3043
2018
Q3 		$32K Buy
+167
New +$35.1K ﹤0.01% 3108

Other funds holding DNTH

TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

American International Group's DNTH Position: Q2 2022 in Review

American International Group sold out of Dianthus Therapeutics (DNTH) in Q2 2022, closing a stake of 928 shares — an estimated $43K sold.

American International Group first reported a position in DNTH in Q3 2018 and held it in 15 quarters. The position peaked at $183K in Q2 2019. 75 funds tracked by Wall St. Rank hold DNTH as of Q2 2022.

  • American International Group reported no remaining Dianthus Therapeutics position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 928 Dianthus Therapeutics shares in Q2 2022, an estimated $43K.
  • American International Group first reported a position in Dianthus Therapeutics in Q3 2018 and held it in 15 quarters.
  • American International Group's Dianthus Therapeutics position peaked at $183K in Q2 2019.
  • 75 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.